BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20494539)

  • 21. Pancreaticoduodenectomy of ampullary carcinoma.
    Roberts RH; Krige JE; Bornman PC; Terblanche J
    Am Surg; 1999 Nov; 65(11):1043-8. PubMed ID: 10551754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiating between benign and malignant ampullary strictures: a prediction model using a nomogram based on CT imaging and clinical findings.
    Lee JE; Choi SY; Lee MH; Lim S; Min JH; Hwang JA; Lee S; Kim JH
    Eur Radiol; 2022 Nov; 32(11):7566-7577. PubMed ID: 35585200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does intravenous glucagon improve common bile duct visualisation during magnetic resonance cholangiopancreatography? Results in 42 patients.
    Dalal PU; Howlett DC; Sallomi DF; Marchbank ND; Watson GM; Marr A; Dunk AA; Smith AD
    Eur J Radiol; 2004 Mar; 49(3):258-61. PubMed ID: 14962656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Jang JY; Kim SW; Kang GH; Yoon YB
    Ann Surg Oncol; 2007 Nov; 14(11):3195-201. PubMed ID: 17710498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ampullary obstruction monitoring in acute gallstone pancreatitis: a safe, accurate, and reliable method to detect pancreatic ductal obstruction.
    Acosta JM; Ronzano GD; Pellegrini CA
    Am J Gastroenterol; 2000 Jan; 95(1):122-7. PubMed ID: 10638569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine cells in ampullary carcinoma.
    Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Funata N
    J Hepatobiliary Pancreat Surg; 2009; 16(3):322-7. PubMed ID: 19214369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MRI cholangiography with rapid spin-echo technique: prospective evaluation of 20 patients].
    Rondeau Y; Soyer P; Meduri B; Spelle L; Gouhiri M; Aubert A; Scherrer A; Rymer R
    J Radiol; 1998 Feb; 79(2):147-52. PubMed ID: 9757232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenomyoma and adenomyomatous hyperplasia of the Vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases.
    Handra-Luca A; Terris B; Couvelard A; Bonte H; Flejou JF
    Mod Pathol; 2003 Jun; 16(6):530-6. PubMed ID: 12808057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ampullary and periampullary tumors].
    Di Bello MG; Giacinti I; Marzano PF; Maturo A; Di Matteo FM; Micacchi M; Petrassi P; Zaccagnino P; Di Curzio B; Polla A; Cappelletti F
    G Chir; 1997 Oct; 18(10):541-3. PubMed ID: 9479959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of magnetic resonance cholangiography and direct cholangiography.
    Alcaraz MJ; De la Morena EJ; Polo A; Ramos A; De la Cal MA; González Mandly A
    Rev Esp Enferm Dig; 2000 Jul; 92(7):427-38. PubMed ID: 11026760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of fat-suppressed T1-weighted MRI using orally administered superparamagnetic iron oxide for revealing ampullary carcinomas.
    Kim YK; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(4):519-25. PubMed ID: 17882025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDCT and MRI of the ampulla of Vater. Part I: technique optimization, normal anatomy, and epithelial neoplasms.
    Alessandrino F; Ivanovic AM; Yee EU; Radulovic D; Souza D; Mortele KJ
    Abdom Imaging; 2015 Oct; 40(8):3274-91. PubMed ID: 26306515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-icteric ampullary carcinoma with a favorable prognosis.
    Yamaguchi K; Enjoji M; Kitamura K
    Am J Gastroenterol; 1990 Aug; 85(8):994-9. PubMed ID: 2375329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of a benign epithelial ampullary tumor to adenocarcinoma.
    Gouma DJ; Obertop H; Vismans J; Willebrand D; Soeters PB
    Surgery; 1987 Apr; 101(4):501-4. PubMed ID: 3563897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings.
    Pilleul F; Rochette A; Partensky C; Scoazec JY; Bernard P; Valette PJ
    J Magn Reson Imaging; 2005 Mar; 21(3):237-44. PubMed ID: 15723374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other "mass forming" pancreatic lesions.
    Sepehr A; Mino-Kenudson M; Ogawa F; Brugge WR; Deshpande V; Lauwers GY
    Am J Surg Pathol; 2008 Dec; 32(12):1770-9. PubMed ID: 18779730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ampulla of Vater: comprehensive anatomy, MR imaging of pathologic conditions, and correlation with endoscopy.
    Kim TU; Kim S; Lee JW; Woo SK; Lee TH; Choo KS; Kim CW; Kim GH; Kang DH
    Eur J Radiol; 2008 Apr; 66(1):48-64. PubMed ID: 17531414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients.
    Santini D; Vincenzi B; Tonini G; Scarpa S; Vasaturo F; Malacrino C; Vecchio F; Borzomati D; Valeri S; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    Clin Cancer Res; 2005 May; 11(10):3784-9. PubMed ID: 15897577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using multi-detector-row CT to diagnose ampullary adenoma or adenocarcinoma in situ.
    Lee M; Kim MJ; Park MS; Choi JY; Chung YE
    Eur J Radiol; 2011 Dec; 80(3):e340-5. PubMed ID: 21093190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.